Soriot Makes Changes At AstraZeneca As The Pharma Explores Its Options
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca’s Soriot makes big moves on his first day on the job – putting a hold on the company’s share-repurchase program and causing speculation that a big acquisition is set for the near future.